Freestone Grove Partners’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
VCM
VPM
Freestone Grove Partners's PODD Position: Q1 2026 in Review
Freestone Grove Partners increased its Insulet (PODD) stake by 14% in Q1 2026, buying an estimated $7.05M and bringing the position to 226,560 shares worth $47.5M. The position accounts for 0.34% of the portfolio, ranked #99.
Freestone Grove Partners first reported a position in PODD in Q4 2024 and has held it in 6 quarters since. The position peaked at $56.4M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.
- Freestone Grove Partners held 226,560 shares of Insulet worth $47.5M as of Q1 2026.
- Freestone Grove Partners bought 28,070 Insulet shares in Q1 2026, an estimated $7.05M.
- Insulet made up 0.34% of Freestone Grove Partners's portfolio in Q1 2026, its #99 holding.
- Freestone Grove Partners first reported a position in Insulet in Q4 2024 and has held it in 6 quarters since.
- Freestone Grove Partners's Insulet position peaked at $56.4M in Q4 2025.
- 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.